Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | RVTY | CAI | ||
| Company | Charles River Laboratories Intl | Revvity Inc | Caris Life Sciences Inc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | ||
| Open | 202.69 | 97.10 | 28.08 | ||
| High | 204.01 | 97.54 | 28.47 | ||
| Low | 201.04 | 96.17 | 28.03 | ||
| Latest | 203.16 | 96.78 | 28.24 | ||
| Change | +0.29 | -0.80 | +0.24 | ||
| % Change | +0.14% | -0.82% | +0.86% | ||
| Volume | 241,900 | 366,600 | 551,100 | ||
| 20-Day Average Volume | 702,700 | 1,215,590 | 2,705,165 | ||
| Previous Close | 202.87 | 97.58 | 28.00 | ||
| Industry | Medical Services | Medical Services | Medical Services | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 190.28 | 100.20 | 27.26 | ||
| 20-Day Raw Stochastic | 95.84% | 12.82% | 80.25% | ||
| 20-Day Relative Strength | 67.26 | 48.89 | 53.11 | ||
| Weighted Alpha | +35.89 | -10.30 | -2.44 | ||
| Today's Opinion | 100% Buy | 56% Buy | N/A | ||
| Previous Opinion | 100% Buy | 72% Buy | N/A | ||
| Last Month's Opinion | 72% Buy | 40% Buy | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.66% since 12/17/25 | +0.01% since 12/17/25 | +3.86% since 12/17/25 | ||
| Low | 191.89 on 12/19/25 | 95.49 on 12/19/25 | 27.00 on 12/18/25 | ||
| High | 204.47 on 12/22/25 | 98.68 on 12/18/25 | 28.71 on 12/22/25 | ||
| 1-Month | |||||
| %Chg | +19.20% since 11/24/25 | -3.78% since 11/24/25 | +12.29% since 11/24/25 | ||
| Low | 170.51 on 11/25/25 | 95.44 on 12/16/25 | 24.38 on 11/28/25 | ||
| High | 204.47 on 12/22/25 | 106.52 on 11/25/25 | 29.19 on 12/08/25 | ||
| 3-Month | |||||
| %Chg | +35.94% since 09/24/25 | +14.55% since 09/24/25 | -7.23% since 09/24/25 | ||
| Low | 144.26 on 09/25/25 | 82.47 on 09/25/25 | 22.86 on 11/07/25 | ||
| High | 204.47 on 12/22/25 | 106.52 on 11/25/25 | 33.65 on 10/07/25 | ||
| 6-Month | |||||
| %Chg | +36.90% since 06/24/25 | +0.40% since 06/24/25 | +1.95% since 06/24/25 | ||
| Low | 144.26 on 09/25/25 | 81.36 on 09/04/25 | 22.86 on 11/07/25 | ||
| High | 204.47 on 12/22/25 | 106.52 on 11/25/25 | 42.50 on 08/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,998,519 | 10,972,529 | 7,967,831 | ||
| Shares Outstanding, K | 49,215 | 113,376 | 282,147 | ||
| Annual Sales | 4,049,990,000 | 2,755,030,000 | 294,010,000 | ||
| Annual Net Income | 22,200,000 | 270,390,000 | 27,730,000 | ||
| Last Quarter Sales | 1,004,850,000 | 698,950,000 | 216,833,000 | ||
| Last Quarter Net Income | 54,420,000 | 46,650,000 | 24,325,000 | ||
| 60-Month Beta | 1.63 | 1.06 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.43 on 11/05/25 | 1.18 on 10/27/25 | 0.08 on 11/05/25 | ||
| Latest Earnings Date | 02/18/26 | 01/30/26 | 02/04/26 | ||
| Most Recent Dividend | N/A | 0.070 on 10/17/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 01/16/26 | 09/09/21 | ||
| Ratios | |||||
| Price/Earnings ttm | 19.23 | 20.37 | 0.00 | ||